Clinical factors affecting the survival of patients diagnosed with non-small cell lung cancer and metastatic malignant pleural effusion, treated with hyperthermic intrathoracic chemotherapy or chemical talc pleurodesis: a monocentric, prospective...
Title | Clinical factors affecting the survival of patients diagnosed with non-small cell lung cancer and metastatic malignant pleural effusion, treated with hyperthermic intrathoracic chemotherapy or chemical talc pleurodesis: a monocentric, prospective... |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Kleontas, A., Sioga A., Pandria N., Barbetakis N., Lazopoulos A., Katsikas I., Asteriou C., Paliouras D., Kamperis E., Ikonomou D., Papamitsou T., Filippou D., Destouni C., Ikonomou L., Zarogoulidis K., & Papagiannopoulos K. |
Journal | J Thorac Dis |
Volume | 11 |
Issue | 5 |
Pagination | 1788-1798 |
Date Published | 2019 May |
ISSN | 2072-1439 |
Abstract | Background: There is a plethora of treatment algorithms for managing patients with malignant pleural effusions (MPEs), sharing many common points and principles. Our study aims to compare hyperthermic intrapleural chemotherapy (HITHOC) and talc pleurodesis (TALC), as treatment options for patients with non-small cell lung cancer (NSCLC) and metastatic MPE. |
DOI | 10.21037/jtd.2019.05.25 |
Alternate Journal | J Thorac Dis |
PubMed ID | 31285871 |
PubMed Central ID | PMC6588789 |